دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Effect of Prophylactic Negative Pressure Wound Therapy vs Standard Wound Dressing on Surgical-Site Infection in Obese Women After Cesarean DeliveryA Randomized Clinical Trial
Methodius G. Tuuli, MD, MPH, MBA; Jingxia Liu, PhD; Alan T. N. Tita, MD, PhD; et al.
doi : 10.1001/jama.2020.13361
JAMA. 2020;324(12):1180-1189.
This open-label randomized trial compares the effects of preventive negative pressure wound therapy vs standard wound dressing on surgical site infection among obese women after cesarean delivery.
Trends in Blood Pressure Control Among US Adults With Hypertension, 1999-2000 to 2017-2018
Paul Muntner, PhD; Shakia T. Hardy, PhD; Lawrence J. Fine, MD; et al.
doi : 10.1001/jama.2020.14545
JAMA. 2020;324(12):1190-1200.
This study uses US National Health and Nutrition Examination Survey data to characterize changes in blood pressure control among adults with hypertension between 1999-2000 and 2017-2018 overall and by age, race, insurance type, and health care access.
Effect of Multilevel Upper Airway Surgery vs Medical Management on the Apnea-Hypopnea Index and Patient-Reported Daytime Sleepiness Among Patients With Moderate or Severe Obstructive Sleep ApneaThe SAMS Randomized Clinical Trial
Stuart MacKay, MD; A. Simon Carney, DM; Peter G. Catcheside, PhD; et al.
doi : 10.1001/jama.2020.14265
JAMA. 2020;324(12):1168-1179.
This randomized clinical trial compares the effect of multilevel airway surgery (combined palatal and tongue surgery) vs ongoing medical management on apnea-hypopnea index (AHI) measures and daytime sleepiness symptoms in patients with obstructive sleep apnea (OSA) whose condition did not respond to CPAP treatment.
Trends in Obesity Prevalence by Race and Hispanic Origin—1999-2000 to 2017-2018
Cynthia L. Ogden, PhD; Cheryl D. Fryar, MSPH; Crescent B. Martin, MA, MPH; et al.
doi : 10.1001/jama.2020.14590
JAMA. 2020;324(12):1208-1210.
This study uses NHANES data to assess trends in obesity and severe obesity stratified by race and Hispanic origin among US residents from 1999 to 2018.
Association Between Number of In-Person Health Care Visits and SARS-CoV-2 Infection in Obstetrical Patients
Sharon C. Reale, MD; Kara G. Fields, MS; Mario I. Lumbreras-Marquez, MBBS, MMSc; et al.
doi : 10.1001/jama.2020.15242
JAMA. 2020;324(12):1210-1212.
This case-control study estimates the risk of contracting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among pregnant women making antenatal visits to 4 Boston, Massachusetts, area hospitals during April-June 2020 vs uninfected controls matched on gestational age.
Geographic Distribution of US Cohorts Used to Train Deep Learning Algorithms
Amit Kaushal, MD, PhD; Russ Altman, MD, PhD; Curt Langlotz, MD, PhD
doi : 10.1001/jama.2020.12067
JAMA. 2020;324(12):1212-1213.
This study describes the US geographic distribution of patient cohorts used to train deep learning algorithms in published radiology, ophthalmology, dermatology, pathology, gastroenterology, and cardiology machine learning articles published in 2015-2019.
Cardiology and COVID-19
Robert O. Bonow, MD, MS; Patrick T. O’Gara, MD; Clyde W. Yancy, MD, MSc
doi : 10.1001/jama.2020.15088
JAMA. 2020;324(12):1131-1132.
In this Viewpoint, JAMA Cardiology editors review the journal's more inportant articles advancing the scientific understanding of COVID-19 and the heart in the first 6 months of the pandemic, including evidence of direct myocardial injury and indirect effects of the pandemic on outcomes for patients with CVD postponing care for fear of contracting the virus.
Dermatology and COVID-19
Kanade Shinkai, MD, PhD; Anna L. Bruckner, MD, MSCS
doi : 10.1001/jama.2020.15276
JAMA. 2020;324(12):1133-1134.
In this Viewpoint, JAMA Dermatology editors review the skin findings seen in association with coronavirus disease 2019 (COVID-19), how best to respond to those manifestations, and ways the pandemic has affected the practice of dermatology, including reassignment of specialists to COVID-19 care and the transition to teledermatology.
Internal Medicine and COVID-19
Rita F. Redberg, MD, MSc; Mitchell Katz, MD; Robert Steinbrook, MD
doi : 10.1001/jama.2020.15145
JAMA. 2020;324(12):1135-1136.
In this Viewpoint, JAMA Internal Medicine editors offer a broad review of the clinical science emerging from the first 6 months of the coronavirus disease 2019 (COVID-19) pandemic, including epidemiology of the infection, evidence that has influenced clinical care, and a discussion of workforce and supply chain issues and health inequities affecting patients and essential workers.
Nephrology and COVID-19
Wolfgang C. Winkelmayer, MD, MPH, ScD; Pascale Khairallah, MD; David M. Charytan, MD
doi : 10.1001/jama.2020.16779
JAMA. 2020;324(12):1137-1138.
In this Viewpoint, JAMA’s nephrology associate editor and colleagues review how COVID-19 has affected the practice of nephrology, including the rise in incidence of acute kidney injury (AKI) in patients with more severe disease, shortages of supplies and staff to care for AKI patients, effects on kidney transplantation, and implementation of telehealth.
Neurology and COVID-19
S. Andrew Josephson, MD; Hooman Kamel, MD
doi : 10.1001/jama.2020.14254
JAMA. 2020;324(12):1139-1140.
In this Viewpoint, JAMA Neurology editors review the journal’s more important articles advancing scientific understanding of COVID-19 in the first 6 months of the pandemic, including surveys of neurologic manifestations of the infection and identification of potential direct viral involvement in the central nervous system.
Oncology and COVID-19
doi : 10.1001/jama.2020.16945
JAMA. 2020;324(12):1141-1142.
This Viewpoint summarizes the clinical characteristics of patients with cancer as associated with increased mortality risk from COVID-19, and it highlights important areas where more research is needed.
Ophthalmology and COVID-19
Neil M. Bressler, MD
doi : 10.1001/jama.2020.17595
JAMA. 2020;324(12):1143-1144.
In this Viewpoint, JAMA Ophthalmology’s editor reviews the known eye manifestations of COVID-19, the potential for ocular transmission of illness, and the effects of the pandemic on ophthalmologic practice and research.
Otolaryngology–Head and Neck Surgery and COVID-19
Jay F. Piccirillo, MD
doi : 10.1001/jama.2020.15779
JAMA. 2020;324(12):1145-1146.
In this Viewpoint, JAMA Otolaryngology–Head & Neck Surgery’s editor in chief reviews how the COVID-19 pandemic has affected the practice of otolaryngology–head and neck surgery in its first 6 months, including through a shift away from procedural management of head and neck disease toward medical and noninvasive management to mitigate risk of infection transmission, and through the acute rise in incidence of patients with olfactory dysunction requiring consultation and follow-up.
Pediatrics and COVID-19
Dimitri A. Christakis, MD, MPH
doi : 10.1001/jama.2020.14297
JAMA. 2020;324(12):1147-1148.
In this Viewpoint, the editor of JAMA Pediatrics summarizes the effect on children of the first 6 months of the COVID-19 pandemic, reviewing evidence for why they seem not to become ill or as sick as adults and discussing the pandemic’s likely long-term effects on child development and psychological health.
Psychiatry and COVID-19
Dost ?ngür, MD, PhD; Roy Perlis, MD, MSc; Donald Goff, MD
doi : 10.1001/jama.2020.14294
JAMA. 2020;324(12):1149-1150.
In this Viewpoint, JAMA Network’s psychiatry editors review how the coronavirus disease 2019 (COVID-19) pandemic has affected the practice of psychiatry in its first 6 months, for example, through disruptions of care provided in group settings, provision of telehealth, and widespread anxiety and health care worker burnout and depression.
Surgery and COVID-19
Melina R. Kibbe, MD
doi : 10.1001/jama.2020.15191
JAMA. 2020;324(12):1151-1152.
In this Viewpoint JAMA Surgery’s editor reviews how the COVID-19 pandemic has affected the practice of general surgery in its first 6 months, including the need for universal precautions to mitigate the risks of infection transmission, the cessation and resumption of elective procedures, and adverse effects on educational experiences of students aspiring to the specialty.
JAMA Network Open and COVID-19
Frederick P. Rivara, MD, MPH; Stephan D. Fihn, MD, MPH; Eli N. Perencevich, MD, MS
doi : 10.1001/jama.2020.15194
JAMA. 2020;324(12):1153-1154.
In this Viewpoint, JAMA Network Open editors review the journal's more important articles advancing scientific understanding of COVID-19 in the first 6 months of the pandemic, and discuss the importance of a global open access journal to meeting the public health challenge.
JAMA Health Forum and COVID-19
John Z. Ayanian, MD, MPP
doi : 10.1001/jama.2020.18432
JAMA. 2020;324(12):1155-1156.
In this Viewpoint, JAMA Health Forum’s editor reviews important policy issues that characterized the first 6 months of the COVID-19 pandemic, including personal protective equipment (PPE) shortages, health inequities among vulnerable populations, requests from patients for medical exemptions from face mask requirements, and the benefits and risks of school reopenings.
Running on Fumes
Bernard E. Trappey, MD
doi : 10.1001/jama.2020.17249
JAMA. 2020;324(12):1157-1158.
In this narrative medicine essay, a hospitalist charts his emotional journey from March comparing the elation in seeing the once brightly colored signs that declared hospital workers as heroes with the now faded signs reflecting how the protracted intense work makes COVID-19 feel mundane.
The COVID-19 Pandemic and the JAMA Network
Michael Berkwits, MD, MSCE; Annette Flanagin, RN, MA; Howard Bauchner, MD; et al.
doi : 10.1001/jama.2020.18298
JAMA. 2020;324(12):1159-1160.
Upper Airway Surgery for Obstructive Sleep Apnea
Meghna P. Mansukhani, MD; Eric J. Olson, MD; Sean M. Caples, DO, MS
doi : 10.1001/jama.2020.9332
JAMA. 2020;324(12):1161-1162.
Obesity and Hypertension in the Time of COVID-19
Griffin P. Rodgers, MD; Gary H. Gibbons, MD
doi : 10.1001/jama.2020.16753
JAMA. 2020;324(12):1163-1165.
Treatment and Control of Hypertension in 2020The Need for Substantial Improvement
Gregory Curfman, MD; Howard Bauchner, MD; Philip Greenland, MD
doi : 10.1001/jama.2020.13322
JAMA. 2020;324(12):1166-1167.
Intimate Partner ViolenceRecognizing and Responding Safely
Harriet L. MacMillan, CM, MD, MSc; Melissa Kimber, PhD, MSW, RSW; Donna E. Stewart, CM, MD
doi : 10.1001/jama.2020.11322
JAMA. 2020;324(12):1201-1202.
This JAMA Insights Clinical Update reviews clinical indicators of intimate partner violence (IPV) and ways that clinicians can ask about and begin to assist individuals who experienced IPV in phased, sensitive approaches that do not encourage patients to act before they are ready or compromise their autonomy or safety.
Ulcerative Colitis in Adults
Laura R. Glick, MD; Adam S. Cifu, MD; Lauren Feld, MD
doi : 10.1001/jama.2020.11583
JAMA. 2020;324(12):1205-1206.
This JAMA Clinical Guidelines Synopsis summarizes the American College of Gastroenterology’s 2019 guideline on ulcerative colitis in adults.
A Patient With Back Pain and Morning Stiffness
Sameet Sangha, MD, MPH; Petar Lenert, MD, PhD; Bharat Kumar, MD, MME, RhMSUS
doi : 10.1001/jama.2020.6261
JAMA. 2020;324(12):1203-1204.
A 44-year-old White man had symptoms and radiographic signs of diffuse osteoarthritis, negative inflammatory markers and HLA-B27, and a brother with osteoarthritis, hypogonadism, and type 2 diabetes. What is the diagnosis and what would you do next?
COVID-19 and mRNA Vaccines—First Large Test for a New Approach
Jennifer Abbasi
doi : 10.1001/jama.2020.16866
JAMA. 2020;324(12):1125-1127.
This Medical News article discusses the leading vaccine candidates against the novel coronavirus.
Pandemic’s Mental Health Toll Grows
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2020.17280
JAMA. 2020;324(12):1130.
Hand Sanitizer Poisoning and Deaths Reported in 2 States
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2020.16614
JAMA. 2020;324(12):1130.
Novel Device Improves Barrett Esophagus Diagnosis in Primary Care
Anita Slomski, MA
doi : 10.1001/jama.2020.16164
JAMA. 2020;324(12):1129.
Baloxavir Protects Against Household Influenza Spread
Anita Slomski, MA
doi : 10.1001/jama.2020.17522
JAMA. 2020;324(12):1129.
Shared Decision-making Doesn’t Change Anticoagulation Treatment
Anita Slomski, MA
doi : 10.1001/jama.2020.17523
JAMA. 2020;324(12):1129.
Intravenous Ibuprofen Reduces Opioids After Orthopedic Trauma
Anita Slomski, MA
doi : 10.1001/jama.2020.17524
JAMA. 2020;324(12):1129.
Mixed Results for Progesterone for Miscarriage Prevention
Anita Slomski, MA
doi : 10.1001/jama.2020.17525
JAMA. 2020;324(12):1129.
Declines in Lung Cancer Deaths Linked to Treatment Advances
Rita Rubin, MA
doi : 10.1001/jama.2020.16750
JAMA. 2020;324(12):1128.
Buprenorphine Implants, Injections Are Underused
Rita Rubin, MA
doi : 10.1001/jama.2020.17587
JAMA. 2020;324(12):1128.
VA Partners With OnStar to Increase Access to Suicide Prevention Services
Rita Rubin, MA
doi : 10.1001/jama.2020.17588
JAMA. 2020;324(12):1128.
The Exact Shade of Code Grey—Sutter Psych Hospital
Sandra McPherson
doi : 10.1001/jama.2020.7940
JAMA. 2020;324(12):1218.
Medical Schools in the United States, 2019-2020
Barbara Barzansky, PhD; Sylvia I. Etzel
doi : 10.1001/jama.2020.14744
JAMA. 2020;324(12):1220-1229
This Appendix presents data from the 2019-2020 Liaison Committee on Medical Education (LCME) annual questionnaire detailing information on the number of students, student demographics, curriculum content, and enrollment at US medical schools.
Graduate Medical Education, 2019-2020
Sarah E. Brotherton, PhD; Sylvia I. Etzel
doi : 10.1001/jama.2020.14635
JAMA. 2020;324(12):1230-1250.
This Appendix presents 2019 National GME Census data detailing the numbers and types of ACGME-accredited training programs and the residents and fellows in them.
High Blood Pressure
Angel N. Desai, MD, MPH
doi : 10.1001/jama.2020.11289
JAMA. 2020;324(12):1254-1255.
This JAMA Patient Page explains what high blood pressure is, why it is important to control, the difference between the top (systolic) and bottom (diastolic) numbers, and how it is best treated and prevented.
CMS Quality Measure Development
Reena Duseja, MD, MS; Maria Durham, MBA; Michelle Schreiber, MD
doi : 10.1001/jama.2020.12070
JAMA. 2020;324(12):1213-1214.
CMS Quality Measure Development—Reply
Rishi K. Wadhera, MD, MPP, MPhil; Karen E. Joynt Maddox, MD, MPH; Robert W. Yeh, MD, MSc
doi : 10.1001/jama.2020.12073
JAMA. 2020;324(12):1214-1215.
Physicians and Social Determinants of Health
Annelise Brochier, MPH; Emily Messmer, MPH; Arvin Garg, MD, MPH
doi : 10.1001/jama.2020.12106
JAMA. 2020;324(12):1215.
Physicians and Social Determinants of Health
John Morgan, MD
doi : 10.1001/jama.2020.12112
JAMA. 2020;324(12):1216.
Physicians and Social Determinants of Health
Kevin Hinchey, MD; Sarah Perez McAdoo, MD, MPH; Rebecca D. Blanchard, PhD
doi : 10.1001/jama.2020.12109
JAMA. 2020;324(12):1216-1217.
Physicians and Social Determinants of Health—Reply
Nason Maani, PhD; Sandro Galea, MD, DrPH
doi : 10.1001/jama.2020.12115
JAMA. 2020;324(12):1217.
